CD304 (BDCA-4) Antibody, anti-human, PE-Vio® 770 130-113-518 from Miltenyi Biotec

Product Specs
ItemCD304 (BDCA-4) Antibody, anti-human, PE-Vio® 770
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-113-518
Quantity100 tests in 200 µL
ApplicationsFlow cytometry
Conjugate/TagPE-Vio 770
Reactivityhuman
IsotypeIgG1
CloneAD5-17F6
Hostmouse
Antibody TypePrimary antibodies
NCBI Full Gene Nameneuropilin 1
NCBI Gene AliasesBDCA4, CD304, NP1, NRP, VEGF165R
Clonalitymonoclonal
Concentration1:50
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
TargetCD304 (BDCA-4)
Research AreaFor research use only
Regulatory StatusFor research use only

Add to Compare List

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

(1) SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosisCellDecember 22, 2021Daniel Wendisch et al.300427 CD56 PerCP 5.1 h11,Biolegend,Cat# 362526 "CD304 (BDCA-4)-PE-Vio770, human, AD5-17F6",Miltenyi,Cat# 130-113-518 BV510 Mouse Anti-Human CD141 Clone 1A4 (RUO),BD,Cat# 563298 CD1c PE AD5-8E7,Miltenyi,Cat# 130-113-302 ,, Virus

(2) Cyclophosphamide induces a type I interferon-associated sterile inflammatory response signature in cancer patients' blood cells: implications for cancer chemoimmunotherapyClinical cancer research : an official journal of the American Association for Cancer ResearchAugust 1, 2013Federica Moschella, Giovanni Fernando Torelli, Mara Valentini, Francesca Urbani, Carla Buccione, Maria Teresa Petrucci, Fiammetta Natalino, Filippo Belardelli, Robin Foà, Enrico Proietti

(3) Rapid detection of dendritic cell and monocyte disorders using CD4 as a lineage marker of the human peripheral blood antigen-presenting cell compartmentFrontiers in immunologyJanuary 1, 2013Jardine L, Barge D, Ames-Draycott A, Pagan S, Cookson S, Spickett G, Haniffa M, Collin M, Bigley V.

(4) Human dendritic cell subsets from spleen and blood are similar in phenotype and function but modified by donor health statusJournal of immunology (Baltimore, Md. : 1950)June 1, 2011Mittag D, Proietto AI, Loudovaris T, Mannering SI, Vremec D, Shortman K, Wu L, Harrison LC.

(5) Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigensThe Journal of experimental medicineJune 7, 2010Jongbloed SL, Kassianos AJ, McDonald KJ, Clark GJ, Ju X, Angel CE, Chen CJ, Dunbar PR, Wadley RB, Jeet V, et al.

(6) Plasmacytoid dendritic cells: from specific surface markers to specific cellular functionsHuman immunologyDecember 1, 2002Dzionek A, Inagaki Y, Okawa K, Nagafune J, Röck J, Sohma Y, Winkels G, Zysk M, Yamaguchi Y, Schmitz J.

(7) BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta inductionThe Journal of experimental medicineDecember 17, 2001Dzionek A, Sohma Y, Nagafune J, Cella M, Colonna M, Facchetti F, Günther G, Johnston I, Lanzavecchia A, Nagasaka T, et al.

(8) BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral bloodJournal of immunology (Baltimore, Md. : 1950)December 1, 2000Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S, Buck DW, Schmitz J.

(9) Dendritic cells: multi-lineal and multi-functionalImmunology todaySeptember 1, 2000Grabbe S, Kämpgen E, Schuler G.

Be the First to Write a Review!

CD304 (BDCA-4) Antibody, anti-human, PE-Vio® 770 from Miltenyi Biotec

Miltenyi Biotec

Miltenyi Biotec

Citations (9)

Reviews

CD304 (BDCA-4) Antibody, anti-human, PE-Vio® 770 from Miltenyi Biotec

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map